ATE308343T1 - Trägerhilfstoff - Google Patents

Trägerhilfstoff

Info

Publication number
ATE308343T1
ATE308343T1 AT99929812T AT99929812T ATE308343T1 AT E308343 T1 ATE308343 T1 AT E308343T1 AT 99929812 T AT99929812 T AT 99929812T AT 99929812 T AT99929812 T AT 99929812T AT E308343 T1 ATE308343 T1 AT E308343T1
Authority
AT
Austria
Prior art keywords
carrier aid
aid
carrier
whiteness
trehalose
Prior art date
Application number
AT99929812T
Other languages
English (en)
Inventor
Kazuhiro Oobae
Etsuo Kamada
Shun Ichi Gomi
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Application granted granted Critical
Publication of ATE308343T1 publication Critical patent/ATE308343T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
AT99929812T 1998-07-15 1999-07-13 Trägerhilfstoff ATE308343T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20029598 1998-07-15
JP32356098 1998-11-13
PCT/JP1999/003775 WO2000003735A1 (fr) 1998-07-15 1999-07-13 Excipient

Publications (1)

Publication Number Publication Date
ATE308343T1 true ATE308343T1 (de) 2005-11-15

Family

ID=26512084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929812T ATE308343T1 (de) 1998-07-15 1999-07-13 Trägerhilfstoff

Country Status (10)

Country Link
US (1) US6699845B2 (de)
EP (1) EP1097722B1 (de)
JP (1) JP4748627B2 (de)
KR (1) KR100421264B1 (de)
CN (1) CN1185013C (de)
AT (1) ATE308343T1 (de)
AU (1) AU743109B2 (de)
CA (1) CA2337015C (de)
DE (1) DE69928110T2 (de)
WO (1) WO2000003735A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
EP1460080A1 (de) * 2003-03-21 2004-09-22 Cargill Incorporated Direkt komprimierbare Trehalose in fester Form
WO2004084650A1 (ja) * 2003-03-26 2004-10-07 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 非糖質成分の粉末化方法及び粉末化基剤
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
CN100391541C (zh) * 2006-03-16 2008-06-04 南台科技大学 以胶质类食材制造赋形剂的方法
NZ572106A (en) * 2006-03-31 2010-12-24 Rubicon Res Private Ltd Directly compressible composite for orally disintegrating tablets
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
EP2033643A4 (de) * 2006-06-27 2013-01-02 Daiichi Sankyo Co Ltd Komprimierte zubereitung
EP2101738A2 (de) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Zusammensetzung und verfahren zur herstellung von im mund zerfallenden tabletten
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP5344938B2 (ja) * 2009-01-29 2013-11-20 旭化成ケミカルズ株式会社 崩壊性固形製剤
EP2504002B1 (de) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Behandlung von genotypisierten diabetes-patienten mit dpp-iv-hemmern wie etwa linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
MX2018007700A (es) * 2011-09-21 2023-01-26 Hayashibara Co Procedimiento para producir una composición de partículas que comprende trehalosa dihidrato cristalina.
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina
CA3056678C (en) 2017-10-03 2021-07-20 Mizkan Holdings Co., Ltd. Composition containing fine food particulate complexes, and method for producing same
KR20210052281A (ko) * 2019-10-29 2021-05-10 신에쓰 가가꾸 고교 가부시끼가이샤 캡슐 충전용 조성물 및 이것을 사용한 캡슐 제제의 제조 방법 그리고 캡슐 제제
KR102848723B1 (ko) 2025-04-18 2025-08-21 주식회사 탑시스템 축전부의 방열을 위한 대면적 히트싱크를 갖는 태양광 발전부가 구비된 가로등

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
EP0553777B1 (de) 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
DE627218T1 (de) 1992-02-18 1995-08-24 Nippon Shinyaku Co Ltd Schnelllösliche tablette.
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
DE69332781T2 (de) 1992-12-28 2004-02-12 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reinigung von Trehalose
JP3773062B2 (ja) * 1993-01-29 2006-05-10 味の素株式会社 製剤用添加剤
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
NZ278678A (en) 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
JP3534130B2 (ja) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 医薬品組成物
TW426737B (en) * 1994-06-27 2001-03-21 Hayashibara Biochem Lab Saccharide composition with reduced reducibility, and preparation and uses thereof
JP3616166B2 (ja) 1994-07-19 2005-02-02 株式会社林原生物化学研究所 トレハロースとその製造方法並びに用途
JP2919771B2 (ja) 1995-04-17 1999-07-19 佐藤製薬株式会社 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤
JP3418274B2 (ja) 1995-06-05 2003-06-16 日本化薬株式会社 口腔内感触の良好な錠剤
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
CA2204599A1 (en) 1995-09-07 1997-03-13 Otsuka Pharmaceutical Co., Ltd. Low-pressure tableted effervescent preparation
JP3624038B2 (ja) * 1995-12-11 2005-02-23 株式会社林原生物化学研究所 糖衣固形物及びその製造方法
DE69728857T3 (de) * 1996-02-09 2010-02-18 Quadrant Drug Delivery Ltd., Ruddington Feste arzneimittel enthaltend trehalose
JPH09316006A (ja) 1996-05-29 1997-12-09 Yatsuken:Kk 口腔内溶解性固形製剤
DE69733476T2 (de) 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11116464A (ja) 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 迅速溶解性固形製剤およびその製造法

Also Published As

Publication number Publication date
CN1309570A (zh) 2001-08-22
CA2337015C (en) 2004-09-07
AU4651699A (en) 2000-02-07
KR20010071883A (ko) 2001-07-31
EP1097722B1 (de) 2005-11-02
WO2000003735A1 (fr) 2000-01-27
US20020042393A1 (en) 2002-04-11
JP4748627B2 (ja) 2011-08-17
CN1185013C (zh) 2005-01-19
EP1097722A4 (de) 2002-03-20
EP1097722A1 (de) 2001-05-09
DE69928110D1 (de) 2005-12-08
DE69928110T2 (de) 2006-07-27
US6699845B2 (en) 2004-03-02
AU743109B2 (en) 2002-01-17
KR100421264B1 (ko) 2004-03-18
CA2337015A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
ATE308343T1 (de) Trägerhilfstoff
DE50213155D1 (de) Elektrolumineszierende Anordnungen
EA199900318A1 (ru) Способ производства гранул цеолита х с низким содержанием двуокиси кремния с низким содержанием инертного связующего
IL132238A0 (en) Fungicidal trifluromethylalkylamino - triazolopyrimidines
GR3025639T3 (en) Porous inorganic ultrasound contrast agents
BG101893A (en) Nodulosporic acid derivatives
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
HUP9903536A2 (hu) Bázikus anyaggal stabilizált gyógyászati készítmények
AU5792690A (en) Aqeous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
MY103969A (en) Detergent composition containing perfume
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
ZA963392B (en) Triggered active packagig material
DK0573777T3 (da) Orale, farmaceutiske sammensætninger indeholdende anthocyanosider
ITMI911155A1 (it) Perfluoropolieteri ad elevata viscosita' e basso contenuto di ossigeno perossidico, e procedimento per la loro preparazione
HUT73158A (en) Insecticidal and acaricidal suspension concentrate containing arylpyrrole derivatives
WO1996019686A3 (en) Ferrofluid having oxidation resistance
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
SG63757A1 (en) Adding impurities to improve the efficiency of allngan quantum well led's
GR3033728T3 (en) Tablets containing thioctic acid with a specified size.
NO952138D0 (no) Cefiximpreparat
EP1043387B8 (de) Alkylbenzolsulfonat-Granulate
TR200003413A3 (tr) Granüler organosilan hazir ürün, bunun üretimi için bir islem ve kullanimi
ES2153637T3 (es) Percarbonato de sodio y su procedimiento de obtencion.
AU591525B2 (en) Stabilization of interferons
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties